Short-Term Intensive PTSD Treatment for Military Personnel
Official title: Examining the Efficacy of Short-Term Intensive PTSD Treatment on Psychological and Cognitive Impairment Symptoms
Run by Ohio State University · NCT07680517 · Data updated 2026-11-12
This trial tests whether a brief, massed form of CPT and EMDR can quickly reduce PTSD symptoms and related cognitive problems in active-duty military personnel.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Ohio State University Academic / other |
| Locations | 1 site (Fayetteville, North Carolina) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | August 2028 |
| Study ends | August 2028 |
| Registry record updated | July 2, 2026 |
| Trial ID | NCT07680517 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are active-duty military personnel (JSOC-aligned) aged 18 or older with PTSD or subthreshold PTSD (3 of 4 symptoms) who can consent in English and participate in massed therapy.
✕Probably not a fit
Individuals with active substance use disorder requiring medical management, imminent suicide risk needing inpatient care, or inability to provide informed consent may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants are treatment-seeking military personnel with PTSD or subthreshold PTSD. The study uses a massed format, delivering CPT and EMDR in a condensed 2–3 week period to see if rapid, sustained symptom and cognitive improvements can be achieved in real-world military settings. Treatments are standard, evidence-based psychotherapies (CPT and EMDR) and delivered in an operational military environment. Outcomes focus on PTSD symptom changes and cognitive performance. The study is led by Ohio State University with support from the Congressionally Directed Medical Research Programs and is conducted at Fort Bragg.
Why it matters
Potential benefit: If successful, participants may experience faster relief from PTSD symptoms and improved cognitive functioning.
How similar studies have gone: Prior randomized trials support CPT and EMDR for PTSD, and massed delivery has shown promise in reducing symptoms more quickly in some populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: -Treatment-seeking military personnel (i.e., any assigned or aligned JSOC personnel) who meet diagnostic criteria for PTSD or subthreshold PTSD (i.e., meeting diagnostic threshold for 3 of 4 symptom criteria who are (1) 18 years of age or older; (2) current diagnosis of PTSD or subthreshold PTSD (i.e. meeting diagnostic criteria for 3 of 4 symptom criteria, assessed using the DIAMOND); (3) current military personnel; (4) ability to speak and understand the English language; and (5) ability to complete the informed consent process Exclusion Criteria: * (1) substance use disorder requiring medical management; (2) imminent suicide risk warranting inpatient hospitalization or suicide-focused treatment; and (3) impaired mental status that precludes the ability to provide informed consent (e.g., intoxication, psychosis, mania).
Where it's running
-
Fort Bragg
Fayetteville, North Carolina, United States Recruiting
Study contacts
- Study coordinator: Jaryd Hiser, PhD
- Email: Jaryd.Hiser@osumc.edu
- Phone: 6146858746
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyperbaric Oxygen Therapy for Veterans With TBI and PCS
This study tests whether 40 HBOT sessions can change blood biomarkers in veterans with traumatic brain injury and persistent symptoms, and whether PTSD affects those biomarker changes.
-
Internet-delivered ACT for youth with PTSD and chronic pain
A small pilot study will test a web-based Acceptance and Commitment Therapy program for teens and young adults with PTSD and chronic pain to see if it helps with symptoms and functioning.
-
Reboxetine plus Ritalin vs Dog-Assisted Therapy for PTSD
This study tests whether a drug combo of reboxetine and methylphenidate works better than dog-assisted therapy for people with PTSD.
-
Floatation-REST for frontline workers with post-traumatic stress symptoms
This early pilot tests whether two 60-minute Floatation-REST sessions can be safely tried by frontline healthcare workers and first responders who have post-traumatic stress symptoms, compared to watching a documentary.
-
Exposure by Assessment: Testing AMQ-based EMA on Intrusive Trauma Memories in PTSD
We’re testing whether daily prompts to focus on a traumatic memory (vs. a neutral memory) using a simple at-home EMA can reduce intrusive PTSD memories and overall PTSD symptoms.
-
Hybrid DBT for Veterans to Further Reduce PTSD and Emotion Regulation Problems
This study tests a hybrid dialectical behavior therapy program for veterans with PTSD and emotion regulation issues to see if it helps reduce symptoms and improve daily functioning.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.